Robert W. Baird Raises Qiagen (NYSE:QGEN) Price Target to $52.00

Qiagen (NYSE:QGEN – Free Report) had its price objective upped by Robert W. Baird from $49.00 to $52.00 in a research note published on Friday morning, Benzinga reports. Robert W. Baird currently has an outperform rating on the stock. Other analysts have also recently issued reports about the stock. Wolfe Research upgraded shares of Qiagen […]

Leave a Reply

Your email address will not be published.

Previous post Robert W. Baird Boosts Patrick Industries (NASDAQ:PATK) Price Target to $128.00
Next post The Goldman Sachs Group Trims Moderna (NASDAQ:MRNA) Target Price to $178.00